相关实验视频
Updated: Jun 12, 2025

09:36
Isolated Pancreatic Islet Treatment and Apoptosis Measurement
Published on: May 2, 2025
290
贝塔细胞特异性ZnT8基因缺陷和由此产生的含量损失显著改善了胰岛素分泌
Anthony Piro1, Yihan Luo1, Ziyi Zhang2
1Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Molecular and cellular endocrinology
|September 25, 2024
概括
胰腺β细胞中运输体8的丧失会增加胰岛素分泌. 在这些细胞中补充可以逆转这种效应,这表明通常会抑制胰岛素的释放,影响2型糖尿病的风险.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 代谢疾病 代谢疾病
背景情况:
- 转运体8 (ZnT8) 对于胰腺β细胞功能和胰岛素分泌至关重要.
- ZnT8基因变异与2型糖尿病 (T2D) 风险有关,但其在β细胞中的特定作用尚不清楚.
- 了解ZnT8的功能是探索T2D病变的关键.
研究的目的:
- 研究β细胞特异性ZnT8在调节胰岛素分泌和葡萄糖平衡中的作用.
- 为了阐明由于ZnT8损失而减少的细胞对胰岛素分泌能力的影响.
主要方法:
- 生成一个β细胞特异性ZnT8淘汰赛 (ZnT8 BKO) 鼠标模型.
- 在ZnT8 BKO小鼠中评估了ZnT8表达,含量,血胰岛素水平和葡萄糖耐受性.
- 从孤立的岛屿中测量葡萄糖刺激的胰岛素分泌物,并通过补充剂在人类岛屿中证实了这一发现.
主要成果:
- ZnT8 BKO 岛屿表现出减少的 ZnT8 表达和含量.
- ZnT8 BKO小鼠显示血胰岛素水平升高,葡萄糖耐受性改善.
- 隔离的ZnT8 BKO岛屿显示胰岛素分泌量增加,这种情况通过补充得到正常化.
- 补充抑制了ZnT8 BKO和对照群岛 (包括人类群岛) 的胰岛素分泌.
结论:
- 丧失ZnT8功能导致细胞减少,胰腺β细胞的胰岛素分泌能力增加.
- 这些发现表明,从胰岛素分泌颗粒 (ISG) 中释放的通常会调节胰岛素分泌.
- ZnT8在调节β细胞平衡中的作用对理解和潜在的治疗2型糖尿病有影响.
相关概念视频
Insulin Secretory Vesicles
4.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K
Cell Specific Gene Expression
13.5K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.5K
Insulin: Biosynthesis, Chemistry, and Preparation
364
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
364
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Glucagon-like Receptor Agonists
305
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
305

